Philip Moos, Ph.D.
Assistant Professor, Department of Pharmacology and Toxicology
L. S. Skaggs Hall 30 S 2000 E Rm 201 Salt Lake City, UT 84112
The Moos laboratory’s nanotechnological investigations deal with the toxicology of nanoparticles and their potential application as anticancer agents. The group has been studying metal oxide nanoparticles for mechanisms of toxicity. Dr. Moos’ focus recently has been on ZnO since it demonstrates toxicity in many cell types and we have demonstrated contact-dependence of this cytotoxicity in mammalian cells. The group is currently evaluating the cellular and molecular mechanisms of toxicity. Since most of the work has been done in vitro, interests lie in developing collaborations where these nanoparticles can be evaluated in vivo to determine their toxicity and potential as anticancer agents.